Explore jobs
Find specific jobs
Explore careers
Explore professions
Best companies
Explore companies
Zosano Pharma revenue
Zosano Pharma's revenue is $1.0 million.
What is Zosano Pharma's revenue?
- Zosano Pharma has 53 employees, and the revenue per employee ratio is $18,868.
- Zosano Pharma peak revenue was $1.0M in 2024.
On this page
Zippia finds jobs where you're a top candidate and applies on your behalf.
Zosano Pharma financing
Zosano Pharma received early financing of $90.0M on 2007-11-15.
| Series | Round size | Date |
|---|---|---|
| Series A | $90M | 11/2007 |
| Series B | $30M | 08/2009 |
| Series B | $9M | 03/2010 |
| Series Unknown | $3.1M | 08/2010 |
| Debt Financing | $4.7M | 09/2011 |
| Debt Financing | $3M | 09/2013 |
| Debt Financing | $2.5M | 03/2014 |
| Debt Financing | $1.3M | 12/2014 |
| Post Ipo Debt | $15.0M | 06/2015 |
| Post Ipo Equity | $7.5M | 08/2016 |
| Post Ipo Equity | $29.3M | 03/2017 |
| Post Ipo Equity | $50M | 04/2018 |
| Post Ipo Equity | $11M | 03/2020 |
| Post Ipo Debt | $15.4M | 02/2022 |
Zosano Pharma investors
| Investors | Security type |
|---|---|
| HBM Healthcare Investments AG | Series A |
| ProQuest Investments | Series A |
| New Enterprise Associates (NEA) | Series A |
| Phase4 Ventures | Series A |
| HBM Healthcare Investments AG | Series B |
| New Enterprise Associates (NEA) | Series B |
| ProQuest Investments | Series B |
| Phase4 Ventures | Series B |
| New Enterprise Associates (NEA) | Debt Financing |
| Nomura Holdings Inc. | Debt Financing |
| BioMed Ventures | Debt Financing |
| HERCULES CAPITAL INC | Post Ipo Debt |
| Aisling Capital | Post Ipo Equity |
Search for jobs
Most in demand jobs
Zippia gives an in-depth look into the details of Zosano Pharma, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Zosano Pharma. The employee data is based on information from people who have self-reported their past or current employments at Zosano Pharma. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Zosano Pharma. The data presented on this page does not represent the view of Zosano Pharma and its employees or that of Zippia.
Zosano Pharma may also be known as or be related to Zosano Pharma Corp., Zosano Pharma Corp, Zosano Pharma Corporation, Zosano Pharma and ZOSANO PHARMA CORP.